Profit Or Loss [Abstract]

Egetis Therapeutics - Filing #690710

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
226,000,000 SEK
382,000,000 SEK
Cost of sales
63,000,000 SEK
79,000,000 SEK
Other income
0 SEK
3,000,000 SEK
Profit (loss) from operating activities
1,981,000,000 SEK
1,057,000,000 SEK
Finance income
50,000,000 SEK
13,000,000 SEK
Finance costs
7,000,000 SEK
2,000,000 SEK
Profit (loss) before tax
1,938,000,000 SEK
1,045,000,000 SEK
Tax expense (income)
- SEK
- SEK
Profit (loss)
1,938,000,000 SEK
1,045,000,000 SEK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
10.0
6.0
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
10.0
6.0

Talk to a Data Expert

Have a question? We'll get back to you promptly.